DABIGATREX 110 (Dabigatran Etexilate (110mg)): usage, picture, dosage and more information......

Feb 06, 2024

DABIGATREX 110 

Dabigatran Etexilate (110mg)

DABIGATREX 110 contains Dabigatran Etexilate(110 mg), which is a potent anticoagulant medication widely used to prevent and treat blood clots. This article aims to provide a comprehensive overview of DABIGATREX 110, covering its uses, dosage, side effects, and other essential information.

Introduction

DABIGATREX 110 contains Dabigatran Etexilate, an anticoagulant belonging to the class of direct thrombin inhibitors. The main reason this drug is prescribed to people with non-valvular atrial fibrillation is to lower their risk of stroke and systemic embolism. It is also used in the management and avoidance of pulmonary embolism (PE) and deep vein thrombosis (DVT).

How Does It Work?

 By blocking thrombin, the medication prevents the conversion of fibrinogen to fibrin, thereby inhibiting the development of blood clots. This mechanism of action makes Dabigatran Etexilate effective in reducing the risk of clot-related complications.

Uses of DABIGATREX 110

Prevention of Stroke and Systemic Embolism

DABIGATREX 110 is widely prescribed to patients with non-valvular atrial fibrillation to lower the risk of stroke and systemic embolism. Atrial fibrillation is a common heart rhythm disorder that increases the risk of stroke due to irregular blood flow and clot formation in the heart.

If these clots travel to the lungs, they can cause a potentially life-threatening condition known as pulmonary embolism. DABIGATREX 110 is effective in treating existing DVT and PE and preventing their recurrence.

Post-Surgery Thromboprophylaxis

Patients undergoing major orthopedic surgeries, such as hip or knee replacement, are at high risk of developing blood clots. DABIGATREX 110 is often prescribed as a thromboprophylactic agent to prevent the formation of clots in these high-risk patients.

Dosage and Administration

The dosage of DABIGATREX 110 varies based on the condition being treated and the patient's overall health status. It is essential to follow the prescribed dosage instructions provided by the healthcare professional. Here is a general guideline:

For Stroke and Systemic Embolism Prevention

The recommended dose for preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation is 150 mg taken orally twice daily. However, for certain patients, including those with moderate renal impairment, a dose of 110 mg twice daily may be appropriate.

For Treatment and Prevention of DVT and PE

For the treatment of DVT and PE, the recommended dose is 150 mg taken orally twice daily following 5-10 days of initial treatment with a parenteral anticoagulant.  

Post-Surgery Thromboprophylaxis

The recommended dose for thromboprophylaxis following hip or knee replacement surgery is 110 mg taken orally on the first day post-surgery, followed by 220 mg taken once daily.

Side Effects of DABIGATREX 110

While DABIGATREX 110 is generally well-tolerated, some patients may experience side effects. It is important to be aware of these potential adverse reactions and seek medical attention if necessary.

Common Side Effects

  • Bleeding: As an anticoagulant, DABIGATREX 110 increases the risk of bleeding. Common sites of bleeding include the gastrointestinal tract, urinary tract, and nasal passages. Patients should report any unusual bleeding or bruising to their healthcare provider.
  • Gastrointestinal Issues: Some patients may experience stomach pain, indigestion, or diarrhea.  
  • Allergic Reactions: Although rare, some individuals may develop allergic reactions, including rash, itching, or swelling. 
  • Major Bleeding: In rare cases, DABIGATREX 110 can cause severe bleeding, leading to life-threatening situations. Patients should seek emergency medical help if they experience symptoms such as severe headache, dizziness, or prolonged bleeding.
  • Liver Problems: Although uncommon, liver-related side effects such as elevated liver enzymes or jaundice may occur. Regular monitoring of liver function is recommended for patients on long-term therapy.

Safety Information

Patients taking DABIGATREX 110 should adhere to the following safety guidelines to ensure optimal outcomes and minimize risks:

Regular Monitoring

While routine coagulation monitoring is not required for DABIGATREX 110, regular follow-up appointments with the healthcare provider are essential to assess the patient's response to treatment and adjust the dosage if necessary.

Drug Interactions

DABIGATREX 110 can interact with other medications, including antiplatelet agents, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antibiotics. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.

Avoiding Activities with High Bleeding Risk

Patients on DABIGATREX 110 should avoid activities that may increase the risk of injury or bleeding. These include contact sports, activities involving sharp objects, and heavy lifting.

Informing Healthcare Providers

Patients should inform all healthcare providers, including dentists, about their use of DABIGATREX 110 before undergoing any medical or dental procedures. This is crucial to prevent complications related to bleeding.

Conclusion

DABIGATREX 110 (Dabigatran Etexilate 110mg) is a valuable medication for preventing and treating blood clots, reducing the risk of stroke, and managing conditions like DVT and PE. While it offers significant benefits, patients should be aware of potential side effects and adhere to safety guidelines to ensure the best possible outcomes. Always consult a healthcare professional before starting or adjusting the dosage of DABIGATREX 110 to ensure it is appropriate for your specific medical condition. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information 

Email: info@sterispharma.com /  contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488 

BUY NOW

SHARE WITH